Chazouillères O - Search Results

1

Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial.

Hirschfield GM, Chazouillères O, Drenth JP, Thorburn D, Harrison SA, Landis CS, Mayo MJ, Muir AJ, Trotter JF, Leeming DJ, Karsdal MA, Jaros MJ, Ling L, Kim KH, Rossi SJ, Somaratne RM, DePaoli AM, Beuers U. Hirschfield GM, et al. Among authors: chazouilleres o. J Hepatol. 2019 Mar;70(3):483-493. doi: 10.1016/j.jhep.2018.10.035. Epub 2018 Nov 9. J Hepatol. 2019. PMID: 30414864 Free article. Clinical Trial.

2

Tumor necrosis factor-alpha in liver transplantation and resection. No evidence for a key role in ischemia-reperfusion injury.

Chazouillères O, Guéchot J, Balladur P, Masini JP, Delva E, Laribi A, Giboudeau J, Lienhart A, Parc R, Poupon R, et al. Chazouillères O, et al. J Hepatol. 1992 Nov;16(3):376-9. doi: 10.1016/s0168-8278(05)80673-7. J Hepatol. 1992. PMID: 1487616

3

Effect of bile acids on ischemia-reperfusion liver injury.

Chazouillères O, Ballet F, Legendre C, Bonnefis MT, Rey C, Chrétien Y, Poupon R. Chazouillères O, et al. J Hepatol. 1991 Nov;13(3):318-22. doi: 10.1016/0168-8278(91)90075-m. J Hepatol. 1991. PMID: 1808225

4

Ursodeoxycholic acid for primary sclerosing cholangitis.

Chazouillères O, Poupon R, Capron JP, Metman EH, Dhumeaux D, Amouretti M, Couzigou P, Labayle D, Trinchet JC. Chazouillères O, et al. J Hepatol. 1990 Jul;11(1):120-3. doi: 10.1016/0168-8278(90)90281-u. J Hepatol. 1990. PMID: 1975818

5

Effect of chronic administration of ursodeoxycholic acid on the ileal absorption of endogenous bile acids in man.

Marteau P, Chazouilléres O, Myara A, Jian R, Rambaud JC, Poupon R. Marteau P, et al. Among authors: chazouilleres o. Hepatology. 1990 Nov;12(5):1206-8. doi: 10.1002/hep.1840120521. Hepatology. 1990. PMID: 2227819 Clinical Trial.

6

Effect of liver transplantation on sex-hormone disorders in male patients with alcohol-induced or post-viral hepatitis advanced liver disease.

Guéchot J, Chazouillères O, Loria A, Hannoun L, Balladur P, Parc R, Giboudeau J, Poupon R. Guéchot J, et al. Among authors: chazouilleres o. J Hepatol. 1994 Mar;20(3):426-30. doi: 10.1016/s0168-8278(94)80020-0. J Hepatol. 1994. PMID: 8014456

7

Clinical and biochemical expression of the histopathological lesions of primary biliary cirrhosis. UDCA-PBC Group.

Poupon R, Chazouillères O, Balkau B, Poupon RE. Poupon R, et al. Among authors: chazouilleres o. J Hepatol. 1999 Mar;30(3):408-12. doi: 10.1016/s0168-8278(99)80098-1. J Hepatol. 1999. PMID: 10190722 Clinical Trial.

8

Apolipoprotein E polymorphism, a marker of disease severity in primary biliary cirrhosis?

Corpechot C, Benlian P, Barbu V, Chazouillères O, Poupon RE, Poupon R. Corpechot C, et al. Among authors: chazouilleres o. J Hepatol. 2001 Sep;35(3):324-8. doi: 10.1016/s0168-8278(01)00137-4. J Hepatol. 2001. PMID: 11592592

9

Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis.

Poupon RE, Lindor KD, Parés A, Chazouillères O, Poupon R, Heathcote EJ. Poupon RE, et al. Among authors: chazouilleres o. J Hepatol. 2003 Jul;39(1):12-6. doi: 10.1016/s0168-8278(03)00192-2. J Hepatol. 2003. PMID: 12821038 Clinical Trial.

10

Impact of steatosis on progression of fibrosis in patients with mild hepatitis C.

Fartoux L, Chazouillères O, Wendum D, Poupon R, Serfaty L. Fartoux L, et al. Among authors: chazouilleres o. Hepatology. 2005 Jan;41(1):82-7. doi: 10.1002/hep.20519. Hepatology. 2005. PMID: 15690484

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

262 results

Search Page